Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesity.
about
Metabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese MiceHypothalamic transcriptomes of 99 mouse strains reveal trans eQTL hotspots, splicing QTLs and novel non-coding genesSex differences in motivational responses to dietary fat in Syrian hamstersHypothalamic inflammation and gliosis in obesityRadiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans.Sex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice.Non-Neuronal Cells in the Hypothalamic Adaptation to Metabolic SignalsIncreased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetesMicroglia activation due to obesity programs metabolic failure leading to type two diabetes.Infection with the Lyme disease pathogen suppresses innate immunity in mice with diet-induced obesity.Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation.Hypothalamic innate immune reaction in obesity.Obesity Impacts Fever and Sickness Behavior During Acute Systemic Inflammation.Glia: silent partners in energy homeostasis and obesity pathogenesis.Hypothalamic Inflammation and Energy Balance Disruptions: Spotlight on Chemokines.Inhibition of hypothalamic leukemia inhibitory factor exacerbates diet-induced obesity phenotype.Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammationLy6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility.Cell culture models of fatty acid overload: Problems and solutions.Dietary fats promote functional and structural changes in the median eminence blood/spinal fluid interface-the protective role for BDNF.Hypothalamic inflammation in obesity and metabolic disease.Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice.Hypothalamic lipid-laden astrocytes induce microglia migration and activation.Hypothalamic stearoyl-CoA desaturase-2 (SCD2) controls whole-body energy expenditure.TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesityIdentifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 T Cell Accumulation in the Omentum of Obesity-Associated Cancer PatientsHypoxia Inducible Factor as a Central Regulator of Metabolism - Implications for the Development of Obesity
P2860
Q27317248-E5A41A81-E70D-4003-AB4F-E8288623DD12Q28822408-6CFD682E-5E94-4969-B8D9-E55BFDEC483DQ35685251-5A5644ED-C0FF-484E-8DB5-C20722AC2B50Q36143532-B190DD65-A26A-4EBD-BE6F-0185B6BDFC25Q36251173-1E03D892-FF62-4D88-BE05-8620C98725A8Q37661264-5DE3C85E-7B9D-4998-8670-841FF6538C30Q37712631-DB9A0B70-04C5-4994-B93B-DE38BCFA5E73Q37736855-415C3734-5A44-4227-B622-A18736F6641FQ37737776-B8351832-B5EC-419B-B697-05BE2902D476Q37740226-E0EE99E1-FFB2-4ED6-9D5E-56AAA35293E2Q38318601-AB1B73CF-5282-4A8A-AFEB-0C7CF679CECCQ38396688-7667A14E-7F7E-461A-BEFE-05A8D7AA243EQ38738358-4148CF35-528E-4650-8C3D-E88DA8ADCDD1Q39041911-C8C8E43B-DA8E-47FF-8288-6F7626AE7B0FQ41418798-DBC1D7E9-5678-4AE0-8CE0-2762DCC930EBQ41595116-B19FF40D-DB4D-4DCA-A4BD-744507EC3264Q42053661-BB0A15E6-32F1-499D-9236-539B236A5E52Q42644178-8FEE4940-649A-4AC7-B717-B8B5A22FC681Q45955756-CA1D7A28-A563-467D-B008-517524139322Q46258336-D8EE9D49-65CA-4AD7-B4EA-CF688254B50FQ47874076-9D5BEEC3-5A1F-49F5-9DF9-B23F301ABD46Q48374538-688C542F-420F-4E42-A163-BB3C79DD6BF0Q49189820-1B91CB60-9A4B-4BE0-B96D-BB5CB0ED6EB6Q50980954-EC653E77-8BD2-45C6-BF2B-FA3DE846B865Q52148985-C57FB966-0479-4FEF-AA47-CD118AF7DF28Q58610974-B88EAFE1-50C6-4062-8A21-EAE52A9EA773Q58785715-8030B589-582F-49B4-AFB7-EE087B60DF98Q59137763-4D641D4F-1B66-4019-B8F1-AC52CB7D441F
P2860
Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Fractalkine (CX3CL1) is involv ...... ation in experimental obesity.
@en
type
label
Fractalkine (CX3CL1) is involv ...... ation in experimental obesity.
@en
prefLabel
Fractalkine (CX3CL1) is involv ...... ation in experimental obesity.
@en
P2093
P356
P1433
P1476
Fractalkine (CX3CL1) is involv ...... ation in experimental obesity.
@en
P2093
Alexandre H Mattos
Carina Solon
Celso D Ramos
Daniela Razolli
Dioze Guadagnini
Gabriela Souza
Iscia Lopes-Cendes
Joseane Morari
Juliana C Moraes
Licio A Velloso
P304
P356
10.2337/DB13-1495
P407
P577
2014-06-19T00:00:00Z